StockData
Instil Bio, Inc. logo

Instil Bio, Inc. (TIL) stock

TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$5.40−0.35 (-6.09%)

Close on Nov 17, 2026Market cap $36.62MP/E –Yield –

Instil Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Instil Bio's revenue for the twelve months ending Dec 31, 2021 was $0, down 100.0% year over year. For fiscal 2021 it was $0, down 100.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0-100.0%
FY2020Dec 31, 2020$138.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$0–
Q3 FY2021Sep 30, 2021$0-100.0%
Q2 FY2021Jun 30, 2021$0-100.0%
Q1 FY2021Mar 31, 2021$0-100.0%
Q4 FY2020Dec 31, 2020$0–
Q3 FY2020Sep 30, 2020$52.00K–
Q2 FY2020Jun 30, 2020$42.00K–
Q1 FY2020Mar 31, 2020$44.00K–

More Instil Bio figures

See a number that looks wrong?